Due to supply issues of Infanrix Hexa, there are currently restrictions on the number of doses practices can order through the NSW Vaccine Centre and possible delays in receiving this vaccine. The Commonwealth and GSK have advised that these supply issues are expected to resolve during December. A notice about this shortage is being placed on the Alerts page of the. For more information, refer to the TGA medicines shortage page or GSK supply updates page.
New clinical guidelines for anaphylaxis management
The first national standard of care for patients with anaphylaxis has now been released. The guideline emphasises the need for prompt treatment and continuity of patient care between acute and general practice healthcare settings. It includes key information for health care professionals on the recognition of anaphylaxis, the administration of adrenaline, correct positioning, and observation following anaphylaxis.
My Health Record COVID-19 vaccination dashboard
My Health Record has a new COVID-19 vaccination dashboard, including vaccination details, COVID-19 test results, relevant medicines and allergy information and links to the COVID-19 vaccine clinic finder and side effect checker. Consumers can use the new COVID-19 Dashboard tab as a quick reference before a vaccination or booster dose or to get proof of vaccination. This link shows an example dashboard screen. Contact My Health Record Help line 1800 723 471 (Option 2) for assistance
What is the definition of “fully vaccinated”?
ATAGI have developed advice on the definition of fully vaccinated (published 26 Nov) for the purposes of people returning from overseas travel, those individuals who are considered fully vaccinated against COVID-19. This definition may be updated over time based on emerging evidence, as required.
Updated guidance on temporary medical exemptions
There are very few situations where a vaccine is contraindicated and as such, medical exemption is expected to be rarely required. ATAGI have developed guidance for providers (updated 26 Nov) outlining valid reasons and medical conditions that warrant a temporary medical exemption relevant for COVID-19 vaccines.
Pfizer and Moderna – thaw use by date vs manufacture expiry date
It is vital that sites are aware of the differences between the thaw use by date and the manufacture expiry date for the mRNA vaccines (Moderna and Pfizer):
The manufacture expiry date on the vial indicates the expiry for the vaccine vial.
The thaw use by date commences at the time the vials are removed from the freezer or ultra low storage to commence thawing.
Practices must have clear processes to identify and action these dates to prevent vaccine administration errors. Whichever date is earliest is the last date the vaccines should be administered to a patient.
The use by date for Moderna is 30 days from the thaw date, when vials are stored unopened at 2° to 8°C
The use by date for Pfizer is 31 days from the thaw date, when vials are stored unopened at 2° to 8°C
FAQs for COVID-19 vaccine booster shots
This resource is designed to assist health care professionals answer common questions about COVID-19 vaccine booster shots. The resource includes information on why booster shots are required, whether they will be required every year, which vaccines should be used for boosters, and more.
FAQs about pregnancy and COVID-19 vaccination
This factsheet (available language translations) answers commonly asked questions about pregnancy and the COVID-19 vaccines, including when and why pregnant women should get the COVID-19 vaccine, which vaccine to get, and possible side effects.
COVID-19 vaccine safety data for specific populations groups
AusVaxSafety has now published COVID-19 vaccine safety data for the following population groups:
These data provide individuals with a short-term adverse event profile of what to expect in the days following COVID-19 vaccination and are a great resource to assist immunisation providers when counselling patients or answering questions regarding COVID-19 vaccination.
The role and responsibilities of an EN
The role of an Enrolled Nurse (EN) in primary health care is often unclear – what they can do, how their supervision needs to be undertaken, and how to ensure they’re working to their full scope of practice. The APNA podcast addresses roles and responsibilities of an EN in general practice.
FREE online course on the National Immunisation Program
The course is usually $95 but is available free until 1 January 2022. See brochure.
The program is designed to provide students with the skills and knowledge to work directly with patients, clients, families and communities to provide advice and encouragement to ultimately improve immunisation rates for Aboriginal and/or Torres Strait Islander people.
Doherty and NCIRS course in vaccinology and immunisation science
The Doherty and NCIRS course in vaccinology and immunisation science is designed for people relatively new to the area of immunisation and for those wanting to broaden and update their understanding of vaccines, vaccine development and the principles underpinning the introduction and running of immunisation programs.
Register for Module 2-11 here: Registration fee for the remaining 10 modules is A$200 (standard), A$100 (full-time students) or A$100 for 6 or fewer modules.
A short survey for immunisation providers
Help improve vaccine safety surveillance in Australia. Immunisation providers are invited to participate in a short survey to assess the knowledge, attitudes and practices of immunisation providers regarding vaccine safety monitoring in Australia. The survey is part of a study being conducted by researchers at NCIRS.
NCIRS webinar: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes
The final webinar for 2021 will focus on COVID-19 in children and adolescents with an update on:
vaccine recommendations and safety in children and adolescents
the latest data on transmission in schools in Australia, including the experience in NSW since the return to face-to-face learning outcomes in children with COVID-19 and long-term follow-up.
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout. Get involved by submitting questions and comments!
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
Continuing Professional Development (CPD) annual requirements Below is a snapshot of the continuing professional development (CPD) requirements for doctors, these include annual requirements of: completion of a Professional Development Plan 50 hours CPD each year, split across a range of activities: 25 hours – reviewing performance and measuring outcomes (with five hours minimum…
CESPHN’s Annual Report 2022-23 is now live Central and Eastern Sydney PHN has released its Annual Report 2022-23. The Annual Report is a summary of the key achievements and highlights for the PHN over the financial year. It is split into Improving Care Integration, Improving Practice and Commissioning Services to…